Dent Neurologic


Bela Ajtai


Dr. Ajtai is an Attending Neurologist at DENT specializing in memory disorders, dementia and neuroimaging diagnostics. In addition to multiple peer-reviewed journal articles and congress abstracts, Dr. Ajtai authored an MRI anatomy atlas and is co-author of the Neuroimaging CD-ROM of the Continuum series and the anatomy chapter for the 4th ed. of “Cerebral SPECT and PET” by Drs. Van Heertum and Tykofsky. He is first author of the Structural Neuroimaging chapter of Bradley’s Neurology in Clinical Practice textbook, 6th & 7th editions.

Dr. Ajtai co-authored a chapter in Neurologic Clinics on Neuroimaging of Dementia. Most recently, he was first author on an imaging chapter in the CME educational series “Continuum” by the American Academy of Neurology.

He is also a volunteer teaching faculty member, having given several series of lectures on neuroanatomy to residents and students at the Jacobs Neurological Institute. Dr. Ajtai is a member of the American Academy of Neurology and the American Society of Neuroimaging.

"Always a great visit , never have to wait, always prompt and on time taking me in for my appointment. Dr. Ajtai is a wonderful doctor and his staff are wonderful also. The receptionists are very kind and friendly."

Bruce, Google

Open Studies


- Memory Disorders
- Neuroimaging
- Neurology

Board Certifications​

- 2005 Neurology
- 2011 Neuroimaging
- 2016 Neurology


See publications for Bela Ajtai, MD, PhD

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with DENT Neurologic Institute)


- Attending Neurologist, DENT Neurologic Institute


Medical / Graduate Education
Semmelweis University of Medicine, Budapest, Hungary

Millard Fillmore Hospital, Buffalo, NY – Department of Medicine

SUNY at Buffalo, Jacobs Neurological Institute, Buffalo, NY

SUNY at Buffalo, Jacobs Neurological Institute, Buffalo, NY – Neuroimaging

Open Clinical Trials



ENVISION Trial  The objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as ...
Read More →

ADNI4 Trial

ADNI4 Trial The ADNI4 is multi-center, a non-randomized, natural history, non-treatment study. 1,150 participants will be enrolled across three cohorts: cognitively normal (CN), mild cognitive ...
Read More →

ADNI3 Trial

ADNI3 Trial Dent is taking part in an observational study called the ADNI3 Trial. This historic study of brain aging could help change the future ...
Read More →


Simufilam 100 mg for Mild to Moderate Alzheimer's Disease
Read More →

PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects

PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects Inclusion Criteria Age 55-90 years Have a reliable study partner, ...
Read More →

Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3)

The Alzheimer’s Disease Neuroimaging Initiative (also known as ADNI) is a historic study of brain aging looking to help change the future for this disease.
Read More →

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Call us to schedule an appointment

Our entire team, from customer service to patient providers, is focused on the central mission to deliver superior clinical care, advanced neurodiagnostics, clinical research and education that will assist our patients in maximizing their quality of life. We strive to exceed the expectations of our patients, clinical partnerships and community partners.

Scroll to Top